Global Sperm Density Testing Market By Type (Kits, Accessories), By Distribution Channel (Retail Pharmacies, Hospital pharmacies, Online Platforms), By Region, and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2021-2031

Infertility is a medical condition in which a woman is unable to conceive due to certain physical circumstances. However, infertility is related to both women and men. In men, infertility refers to low sperm count, blockages, and abnormal sperm function that prevents the delivery of sperm. Women who can get pregnant but are not able to continue with a healthy pregnancy are also diagnosed with infertility.

Men and women are equally likely to be infertile. These issues of infertility are treated with infertility services to cure fertility and genetic issues related to conception. Fertility services include IVF (In Vitro Fertilization), IUI (Intrauterine Insemination), Intracytoplasmic Sperm Injection (ICSI), and other surgeries or treatment plans to treat infertility.

These services are supported by an initial test such as the sperm density test, hormone test, etc., which are analyzed by a medical representative/practitioner to diagnose and treat a patient accordingly. A semen density/analysis test generates results such as sperm count, sperm appearance, movement analysis, pH analysis, and other factors related to sperm health. These tests can be done at home as well, for analysis at labs, sperm needs to be collected and deposited in-between periods of 30-60 minutes after ejaculation.

Global sperm density testing market is segmented on the basis of type, distribution channel, and region. Listed below is this market’s segmentation:

By Type

• Kits
• Accessories

Distribution Channel

• Retail Pharmacies
• Hospital pharmacies
• Online Platforms

By Region

• North America
  • The US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia-Pacific
  • China
  • Japan
  • India
  • Korea
  • Rest of Asia-Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East and Africa
  • GCC
  • Israel
  • South Africa
  • Rest of MEA

Market Dynamics–

Changing lifestyles, such as increasing alcohol consumption and smoking habits, coupled with unhealthy eating habits, to a certain extent reduce the sperm count. Such abnormal sperm function, lowering testosterone levels, luteinizing hormone, and an increase of estrogen in men are factors that led to an increase in male infertility, further increasing the need for infertility services, strengthening sperm density testing market in the process.

Additionally, growing awareness levels concerning genetic disorders have also resulted in early fertility testing. These tests are beneficial as the transmission of genetic diseases can be restrained, and early measures can be taken to produce healthy offspring. This factor has led to an increase in the number of tests, thereby further increasing this market’s economic trajectory.

Unfortunately, ongoing quality problems concerning medical equipment and other related product recalls may pose potential health risks to patients in hospitals and other medical facilities. A product recall tarnishes a company’s reputation, and users tend to lose trust in their products. These factors are also expected to hamper market growth opportunities to a certain extent.

However, an increase in awareness levels concerning the subject of infertility, coupled with the emergence of cost-effective laboratory testing are expected to offer potential opportunities for further revenue growth.

Competitive Landscape

Major players in the market are –

• Hamilton Thorne Inc.
• Medical Electronic Systems LLC
• Microptic S.L.
• ContraVac Inc.
• MotilityCount ApS
• PROiSER – Projectes i Serveis R+D S.L.
• Dolo Animals Limited
• CooperSurgical Inc.
• Sperm Processor Pvt. Ltd.
• AKYmed Ltd.
• Beijing Weili New Century Science & Tech. Deve. Co. Ltd.
• others

Key Developments:

• In 2020, Finless Foods which specializes in cell-cultured seafood announced that the company plans to launch plant-based tuna in 2022.
• Naturex, specialist in plant-based ingredients announced that it is working on developing alternative to cosmetic color being used for plant-based products.

For the Sperm Density Testing Market research study, the following years have been considered to estimate the market size: